UC San Diego Health-Sulpizio Cardiovascular Center

La Jolla, California 92037

3 studies enrolling now · 7 studies all time

What they study most

Amyloidosis, Immunoglobulin Light-chain, CKD Stage 3, Chronic Heart Failure, Heart Failure, Heart Failure With Reduced Ejection Fraction, Obstructive Hypertrophic Cardiomyopathy (oHCM), Symptomatic Hypertrophic Cardiomyopathy (HCM), Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy

Studies at this site

• Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction — Recruiting now
• Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System — Recruiting now
• A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) — Running, not enrolling
• Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM — Completed
• Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM — Completed
• Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM — Enrolling by invitation
• Cardiac Amyloidosis Registry Study — Status unconfirmed